Correlation Between Aslan Pharmaceuticals and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both Aslan Pharmaceuticals and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aslan Pharmaceuticals and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aslan Pharmaceuticals and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Aslan Pharmaceuticals and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aslan Pharmaceuticals with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aslan Pharmaceuticals and Monte Rosa.
Diversification Opportunities for Aslan Pharmaceuticals and Monte Rosa
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aslan and Monte is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Aslan Pharmaceuticals and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Aslan Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aslan Pharmaceuticals are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Aslan Pharmaceuticals i.e., Aslan Pharmaceuticals and Monte Rosa go up and down completely randomly.
Pair Corralation between Aslan Pharmaceuticals and Monte Rosa
If you would invest 487.00 in Monte Rosa Therapeutics on August 25, 2024 and sell it today you would earn a total of 362.00 from holding Monte Rosa Therapeutics or generate 74.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 4.35% |
| Values | Daily Returns |
Aslan Pharmaceuticals vs. Monte Rosa Therapeutics
Performance |
| Timeline |
| Aslan Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Monte Rosa Therapeutics |
Aslan Pharmaceuticals and Monte Rosa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aslan Pharmaceuticals and Monte Rosa
The main advantage of trading using opposite Aslan Pharmaceuticals and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aslan Pharmaceuticals position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.| Aslan Pharmaceuticals vs. Monte Rosa Therapeutics | Aslan Pharmaceuticals vs. NewAmsterdam Pharma | Aslan Pharmaceuticals vs. Inventiva Sa | Aslan Pharmaceuticals vs. Cullinan Oncology LLC |
| Monte Rosa vs. Eliem Therapeutics | Monte Rosa vs. HCW Biologics | Monte Rosa vs. RenovoRx | Monte Rosa vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |